With measles making a resurgence across North America, health officials are strongly advising individuals to confirm their vaccination status against the highly contagious virus. While breakthrough infections in vaccinated individuals are exceedingly rare, the re-emergence of measles as an endemic disease in the United States underscores the importance of understanding one's immunity.

The measles, mumps, and rubella (M.M.R.) vaccine is the primary defense against the virus, administered as part of routine childhood immunizations. The Centers for Disease Control and Prevention (C.D.C.) indicates that over 90 percent of U.S. children receive at least one dose. For adults, having received two doses of the M.M.R. vaccine at any point in their lives generally confers robust, lifelong protection.

Dr. William Schaffner, an infectious disease specialist at Vanderbilt University Medical Center, explained that even though immunity from any vaccine can diminish over time, the measles vaccine provides strong protection for nearly everyone. The C.D.C. suggests that individuals born before 1957 are likely immune due to widespread measles circulation during that era. For those born after 1957 who are unsure about their vaccination history, tracking down medical records or requesting a blood test to check for measles antibodies are recommended steps.

For the vast majority of individuals who have received two M.M.R. vaccine doses, health authorities do not recommend a booster shot, even in areas experiencing outbreaks. Dr. Amesh Adalja, an infectious disease physician at the Johns Hopkins Center for Health Security, stated that two doses are sufficient and individuals should not worry about needing an additional shot. An exception exists for certain immunocompromised individuals, such as those who have undergone bone marrow transplants, who might require revaccination.

However, individuals who received only one dose of the vaccine may need further assessment. Those vaccinated with a single dose before 1968 might require an additional shot, as earlier versions of the vaccine were less effective. Furthermore, people vaccinated between 1968 and 1989, when only one dose was recommended, may have gaps in their immunity. A single dose is about 93 percent effective, while two doses offer approximately 97 percent protection.

Robert Bednarczyk, an associate professor of global health at Emory University, advises consulting a healthcare provider if you've had only one dose. While Dr. Adalja noted that one dose is still quite effective and there's generally no harm in receiving another, specific circumstances might warrant a second dose. These include international travel or belonging to groups identified by the C.D.C. as needing a second shot, such as school-age children, healthcare workers, college students, and certain individuals with H.I.V.

Public health agencies may also recommend a second dose for specific groups during an outbreak if they are at increased risk. Family members and close contacts of immunocompromised individuals are also advised to get two doses. The ongoing spread of measles highlights the critical need for public awareness regarding vaccination status and adherence to recommended immunization schedules.

Questions remain about the precise duration of immunity for those with only one dose and the specific criteria for recommending boosters in localized outbreak situations. Continued monitoring of measles cases and vaccination rates will be crucial in managing and preventing future outbreaks.